Should You Increase Your Holdings in argenx SE (ARGX)? [Yahoo! Finance]
argenx SE - American Depositary Shares (ARGX)
US:NASDAQ Investor Relations:
investor.argenx.com/phoenix.zhtml?c=254223&p=irol-presentations
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . Within equities, smaller or value-oriented stocks in developed economies yielded higher, whereas emerging markets saw the opposite trend. In the third quarter, the strategy returned 4.96% (gross) and 4.75% (net) while the Russell Midcap Growth Index returned 6.54%. In addition, please check the fund's top five holdings to know its best picks in 2024. TimesSquare Capital U.S. Mid Cap Growth Strategy highlighted stocks like Argenx SE (NASDAQ: ARGX ) in the Q3 2024 investor letter. Argenx SE (NASDAQ:ARGX) is a biotechnology company focused on autoimmune diseases. The one-month return of Argenx SE (NASDAQ:ARGX) was 5.80%, and its shares gained 37.40% of their value over the last 52 weeks. On December 6, 2024, Argenx SE (NASDAQ:ARGX) stock closed at $623.11 per share with a market capitalization of $37.26 billion. TimesSquare Capital U.S. Mid Cap Growth Strategy stated the following regarding Argenx SE (NASDAQ:ARGX) in its Q3 2024 investor
Show less
Read more
Impact Snapshot
Event Time:
ARGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARGX alerts
High impacting argenx SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ARGX
News
- argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating PolyneuropathyGlobeNewswire
- argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $639.00 to $723.00. They now have an "overweight" rating on the stock.MarketBeat
- argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $655.00 price target on the stock.MarketBeat
- Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]Yahoo! Finance
- argenx to Present at Upcoming Investor ConferencesGlobeNewswire
ARGX
Earnings
- 10/31/24 - Beat
ARGX
Sec Filings
- 12/27/24 - Form 6-K
- 11/20/24 - Form 6-K
- 11/14/24 - Form SC
- ARGX's page on the SEC website